Article by David Brown, Lift
Health Canada says it is satisfied that the two companies who recently underwent recalls for the presence of unauthorized pesticides have taken the issue seriously. No other regulatory action will be taken at this time beyond extended expanded monitoring and evaluation.
“The companies have undertaken a series of corrective actions, including strengthening monitoring, enhancing internal operating procedures, and expanding their product testing regimes, says André Gagnon, Media Relations Officer for the regulator. “Health Canada will continue to evaluate the actions taken by these licensed producers to ensure they are in compliance with the regulations regarding the safe and proper use of pesticides on cannabis plants.”
In Late 2016, both OrganiGram and Mettrum issued recall announcements for cannabis sold due to unauthorized pesticides, including myclobutanil and/or bifenazate. In January, this recall was expanded at OrganiGram to include products produced between February 1, 2016 and December 16, 2016. Aurora Cannabis then issued a recall notice shortly after for products they had purchased from OrganiGram. The pesticides in question are myclobutanil in the case of Mettrum and myclobutanil and bifenazate in the case of OrganiGram.
“Health Canada has been in frequent communication with the companies in question, and has undertaken a number of follow up inspections to ensure they are in compliance with federal regulations. The companies have undertaken investigations to try and determine how these unauthorized pesticides were introduced into their supply chain. Based on current evidence, Health Canada is satisfied that the measures put in place will prevent a reoccurrence, however the department will not hesitate to take further regulatory action if warranted.” -André Gagnon, Media Relations Officer for Health Canada
By late January, Health Canada had said the companies had undertaken ‘a series of corrective actions’ against the two producers, “including strengthening monitoring, enhancing internal operating procedures, and expanding their product testing regimes.” In early February, Health Canada added ‘expanded testing regimes’ for both producers.